The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Request Sample of the Report on Global Serum Free and Specialty Media Market 2033 - Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies, and rise ...

Spire Wealth Management bought a new position in Novavax, Inc. (NASDAQ:NVAX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...

For many years, the potential of immunoglobulin M (IgM) antibodies was not fully understood because of characteristics different to the well-known immunoglobulin G type like low target affinity, cross ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...